Indeed, immunohistochemistry identified significantly increased infiltration of CD8 T cells in treated Adam2 knockout tumors but with a concomitant drastic increase expression of the PDL1 exhaustion marker, indicating an immune-suppressive tumor environment (Supplementary Fig. 13). The gene discussed is ADAM2; the disease is neoplasm.